Document is current

Any future updates will be listed below

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Crossref DOI link: https://doi.org/10.1007/s40121-023-00848-4

Published Online: 2023-08-08

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark